PARP Inhibitors: Recent Research Advancements in Prostate Cancer (2025–2026)

PARP inhibitors are among the most significant advances in precision medicine for prostate cancer. These drugs work by blocking DNA […]

Two New Approvals, One Clear Direction — Targeted Drug Therapies Come of Age in 2025

The past year brought two significant FDA approvals that signal where prostate cancer treatment is heading: toward more precise, earlier-acting […]

“Smart” Radiation Gets Smarter — Lutetium-177 Therapy Expands Its Reach

A treatment once reserved for men who had exhausted nearly every other option is now available earlier in the course […]

A New Standard in Detection — PSMA PET Imaging Is Changing How We Find Prostate Cancer

For decades, diagnosing and staging prostate cancer relied on a combination of CT scans, bone scans, and MRI. That picture […]

Brachytherapy (Internal Radiation Therapy)

  Brachytherapy (Internal Radiation Therapy) Brachytherapy is a form of internal radiation therapy where tiny radioactive seeds or temporary radiation […]